Jaypirca (Pirtobrutinib))
Overview
Jaypirca is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat some cases of mantle cell lymphoma (MCL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).… read more